BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26937934)

  • 1. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
    Showalter TN; Camacho F; Cantrell LA; Anderson RT
    Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.
    Schad MD; Moore J; Camacho F; Anderson RT; Cantrell LA; Showalter TN
    Medicine (Baltimore); 2019 Aug; 98(33):e16874. PubMed ID: 31415427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
    Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
    Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
    Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
    Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
    Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
    Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
    Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
    Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
    Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
    Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pretreatment with
    Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
    Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Salvo G; Flores Legarreta A; Ramalingam P; Jhingran A; Bhosale P; Saab R; Gonzales NR; Chisholm GB; Frumovitz M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1359-1369. PubMed ID: 37567596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011.
    Smith GL; Jiang J; Giordano SH; Meyer LA; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):260-7. PubMed ID: 25968823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
    Rauh LA; Saks EJ; Nakad-Rodriguez D; Showalter TN; Duska LR
    Gynecol Oncol; 2018 Aug; 150(2):338-342. PubMed ID: 29935911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer.
    Aghili M; Andalib B; Karimi Moghaddam Z; Maddah Safaie A; Amoozgar Hashemi F; Mousavi Darzikolaie N
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2745-2750. PubMed ID: 30360600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.